Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046436 · ClinicalTrials.gov registry record
Rapid HIV Tests for Women Late in Pregnancy and During Labor
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 7,500
- Enrollment target
NCT00046436 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 7,500 participants.
The verdict
NCT00046436 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 7,500 participants
- Enrollment target
Study Summary
This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Est. Completion | 2004-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046436
The ClinicalTrials.gov registry entry for NCT00046436 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00046436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046436 about?
NCT00046436 is a clinical study titled "Rapid HIV Tests for Women Late in Pregnancy and During Labor". This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.
What is the current status of trial NCT00046436?
This trial is currently terminated. The enrollment target is 7,500 participants. Estimated completion is 2004-03.
Who is sponsoring clinical trial NCT00046436?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.